The analysis, led by the University of Glasgow, found that mild kidney disease is associated with a four percent increase in risk of developing cancer, and a further 15 percent risk of dying from the condition.
In people with more advanced kidney disease, researchers found a 19 percent increased risk in developing cancer and a 48 percent risk of death.
Doctor Jennifer Lees, of the University of Glasgow, said: “Our research suggests that greater uptake of cystatin C testing could be used to improve patient outcomes by identifying cancer risks earlier, thereby increasing patients’ quality of life and chance of survival.”
READ RELATED: Checking for prostate cancer could save your life
Cystatin C is a protein produced by the cells of the body, which is regulated by the kidneys.
READ MORE: Cancer symptoms: The early signs of lung cancer you need to know
Source: Daily Express
